Cargando…

Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy

Detalles Bibliográficos
Autores principales: Rovida, F., Cereda, D., Novati, S., Licari, A., Triarico, A., Marseglia, G.L., Bruno, R., Baldanti, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289743/
https://www.ncbi.nlm.nih.gov/pubmed/32535148
http://dx.doi.org/10.1016/j.cmi.2020.06.006
_version_ 1783545519935586304
author Rovida, F.
Cereda, D.
Novati, S.
Licari, A.
Triarico, A.
Marseglia, G.L.
Bruno, R.
Baldanti, F.
author_facet Rovida, F.
Cereda, D.
Novati, S.
Licari, A.
Triarico, A.
Marseglia, G.L.
Bruno, R.
Baldanti, F.
author_sort Rovida, F.
collection PubMed
description
format Online
Article
Text
id pubmed-7289743
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72897432020-06-12 Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy Rovida, F. Cereda, D. Novati, S. Licari, A. Triarico, A. Marseglia, G.L. Bruno, R. Baldanti, F. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020-11 2020-06-12 /pmc/articles/PMC7289743/ /pubmed/32535148 http://dx.doi.org/10.1016/j.cmi.2020.06.006 Text en © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Rovida, F.
Cereda, D.
Novati, S.
Licari, A.
Triarico, A.
Marseglia, G.L.
Bruno, R.
Baldanti, F.
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
title Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
title_full Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
title_fullStr Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
title_full_unstemmed Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
title_short Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
title_sort low risk for sars-cov2 symptomatic infection and early complications in paediatric patients during the ongoing covid19 epidemics in lombardy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289743/
https://www.ncbi.nlm.nih.gov/pubmed/32535148
http://dx.doi.org/10.1016/j.cmi.2020.06.006
work_keys_str_mv AT rovidaf lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT ceredad lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT novatis lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT licaria lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT triaricoa lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT marsegliagl lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT brunor lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT baldantif lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy
AT lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy